NOS3 and prostate carcinoma: Analysis of a dataset GSE21032 [40] of gene expression microarray performed in clinical prostate cancer tissues further confirmed that eNOS exhibited significant higher expression levels in higher Gleason score (GS) tumor samples as compared to tumors with lower GS (Fig. 1b).